Physician profile
Kevin S Cahill
NPI 1811157613
$1,099,224.11
in general payments reported to CMS, 2019-2025
11 companies · $185K in 2025
The $185K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114K · 2020: $141K · 2021: $89K · 2022: $192K · 2023: $187K · 2024: $192K · 2025: $185K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $564K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $563,540.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $575,154.27 | 2019-2025 | Rise-L . Rise-L A/L, Rise, Creo Dlx |
| Integrity Implants INC. | $222,149.56 | 2019-2022 | Flarehawk |
| Alphatec Spine, INC | $158,536.78 | 2022-2025 | Other - Miscellaneous, Invictus Open, Invictus Mis |
| Integrity Implants INC. Dba Accelus | $141,539.47 | 2023-2024 | Flarehawk |
| Spine Wave, INC. | $1,226.00 | 2019 | |
| Abbott Laboratories | $202.36 | 2019 | |
| Depuy Synthes Sales INC. | $154.83 | 2019-2020 | |
| Medtronic USA, INC. | $91.71 | 2019 | |
| Boston Scientific Corporation | $77.22 | 2021 | |
| Seaspine Orthopedics Corporation | $72.41 | 2021 | |
| Nexxt Spine LLC | $19.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Cahill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.